CAMP4 Therapeutics Corporation
CAMP · NASDAQ
12/31/2024 | 12/31/2023 | 11/30/2023 | 2/28/2023 | |
|---|---|---|---|---|
| Market Cap | $102 | $130 | – | $387 |
| - Cash | $64 | $38 | – | $83 |
| + Debt | $9 | $12 | – | $12 |
| Enterprise Value | $46 | $103 | – | $316 |
| Revenue | $1 | – | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $1 | – | $0 | $0 |
| % Margin | 100% | – | 100% | – |
| EBITDA | -$51 | – | -$50 | -$44 |
| % Margin | -7,882.2% | – | -14,343.1% | – |
| Net Income | -$52 | – | -$49 | -$44 |
| % Margin | -7,943.4% | – | -14,083.1% | – |
| EPS Diluted | -2.66 | – | -4.07 | -0.9 |
| % Growth | – | – | -352.2% | – |
| Operating Cash Flow | -$46 | -$44 | – | -$39 |
| Capital Expenditures | -$0 | -$1 | – | -$4 |
| Free Cash Flow | -$46 | -$45 | – | -$43 |